ABSTRACT
Luteinizing hormone-releasing hormone agonist (LH-RH analogue) therapy, is one of the most widely used hormonal therapies. Recently, subcutaneous injection of a new long acting 3-month LHRH analogue depot has been developed. We investigated the adverse events induced by injection of an LH-RH analogue in 82 patients (median age was 75 year old, 59-87) using our questionnaire. Forty-eight and 34 cases had been administered leuprorelin acetate (LSR) and goserelin acetate (ZLA). The presentation rate of skin reaction was 8.8% (3/34) in the ZLA group and 14.6% (7/48) in the LSR group. There was no significant difference in rate of skin reaction between the LSR and ZLA group (p = 0.5113). Eight patients had induration (6 in LSR 2 in ZLA). We also present a case of subcutaneous granuloma formation at the injection site after using the three-month type preparation of leuprorelin acetate. We should be aware of the risk of skin reactions at the injection site and monitor carefully when using an LH-RH analogue.
Subject(s)
Antineoplastic Agents, Hormonal/administration & dosage , Antineoplastic Agents, Hormonal/adverse effects , Gonadotropin-Releasing Hormone/analogs & derivatives , Goserelin/administration & dosage , Goserelin/adverse effects , Granuloma/etiology , Leuprolide/administration & dosage , Leuprolide/adverse effects , Prostatic Neoplasms/drug therapy , Skin/pathology , Aged , Aged, 80 and over , Granuloma/pathology , Humans , Injections, Subcutaneous/adverse effects , Male , Middle AgedABSTRACT
A fully automated, continuous-flow-through type analyzer was developed to observe rapid changes in the concentration of total inorganic carbon (CT) in coastal zones. Seawater and an H3PO4 solution were fed into the analyzer's mixing coil by two high-precision valveless piston pumps. The CO2 was stripped from the seawater and moved into a carrier gas, using a newly developed continuous-flow-through CO2 extractor. A mass flow controller was used to assure a precise flow rate of the carrier gas. The CO2 concentration was then determined with a nondispersive infrared gas analyzer. This analyzer achieved a time-resolution of as good as 1 min. In field experiments on a shallow reef flat of Shiraho (Ishigaki Island, Southwest Japan), the analyzer detected short-term, yet extreme, variations in CT which manual sampling missed. Analytical values obtained by the analyzer on the boat were compared with those determined by potentiometric titration with a closed cell in a laboratory: CT(flow-through) = 0.980 x CT(titration) + 38.8 with r2 = 0.995 (n = 34; September 1998).
